Ingenus Pharmaceuticals
Ingenus Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 6 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Ingenus Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ingenus-pharmaceuticals
Overview
Ingenus Pharmaceuticals is a pharmaceutical company headquartered in Orlando, United States.
FDA compliance signals
6 FDA enforcement records linked to this company.
- recall — Class II2022-10-26
Out of specification for related substances (impurities).
- recall — Class II2022-01-26
CGMP Deviations
- recall — Class II2019-10-23
Crystallization: Presence of particulate matter identified as API crystallization
- recall — Class III2019-04-03
Defective Container: firm discovered samples stored horizontally as well as product quality complaints from customers for bottles leaking.
- recall — Class II2018-07-11
Superpotent Drug: High out of specification assay value results for potency.
- recall — Class II2018-07-11
Superpotent Drug: High out of specification assay value results for potency.
Is this Ingenus Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.